Navigation Links
Johnson & Johnson Presents Growth Strategies for Medical Devices & Diagnostics Segment
Date:1/22/2013

ulin delivery innovations with a unique "wearable" insulin patch, which when it is introduced, will make it easier for patients who need an easy-to-administer, meal-time dosing solution.

The Global Surgery Group is focused on bringing innovation to the fast-growing Energy market. The recently approved HARMONIC ACE®+ Shears, for example, responds to varying tissue conditions and regulates energy delivery, benefiting both surgeons and their patients. In 2013, the DePuy Synthes Companies are planning to introduce the ATTUNE™ Knee System, which is designed to help patients who are not completely satisfied with current knee replacement systems achieve their optimum performance. More than 2,500 patients have been successfully treated to date.  

Global Reach with Local Focus
Johnson & Johnson also continues to explore ways to expand its global footprint and its MD&D business continues to focus on local market needs. Today, 56 percent of the Johnson & Johnson's revenues come from outside the U.S., compared to about 40 percent a decade ago. Moreover, in the past two years, sales growth in emerging markets grew significantly for Johnson & Johnson. Including Synthes, emerging markets now make up 23 percent of Johnson & Johnson sales.

"One million surgical procedures are performed every day around the world, many of them utilizing the technologies created by Johnson & Johnson's Global Surgery Group," said Gary Pruden , Worldwide Chairman, Global Surgery Group. "We are a highly global business, with about 60 percent of Global Surgery sales currently generated outside the U.S. and a strong and growing presence in emerging markets."

The 2012 acquisition of Guangzhou Bioseal Biotech, a company specializing in porcine plasma-based fibrin sealants used to control bleeding during surgical procedures, gives MD&D access to the fast growing Chinese biosurgery market wit
'/>"/>

SOURCE Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
2. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
3. Johnson & Johnson Postpones Medical Devices & Diagnostics Review
4. Johnson & Johnson to Host Medical Devices & Diagnostics Review
5. Johnson & Johnson Announces Plans to Establish Innovation Centers
6. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
7. Johnson Health Tech Statement on Lance Armstrong
8. EFJohnson Announces Impact Partner Dealer Program
9. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
10. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
11. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  Medical Science Liaisons play a large role in ... medical device industry and key stakeholders, the role of ... as the device industry relies on them to build ... benchmarking firm, Best Practices, LLC, one area where Medical ... by harnessing new technology to enable education. Online conferences ...
(Date:12/22/2014)... , Dec. 22, 2014 Apnea Sciences ... corporate offices in Aliso Viejo , ... due to the tremendous growth and worldwide expansion, a ... of patented SnoreRx, the anti snore cure have exceeded ... said, "We are now in 23 countries and ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2Investment Analysis of the US Medical Device Sector 2
... Matrixx Initiatives, Inc. (Nasdaq: MTXX ), an over-the-counter healthcare company, announced today ... March 31, 2010 , will be released after the market closes on ... following morning on Tuesday, May 11, 2010 at 11:00 AM ... To access the teleconference, ...
... that a new market research report is available in its catalogue: , ... Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence ... http://www.reportlinker.com/p0191948/Stakeholder-Opinions-Cardiovascular-and-Metabolic-Generics----Generics-continue-to-gain-prominence.html , ... , , , ...
Cached Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Fourth Quarter and Fiscal 2010 Financial Results 2Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 2Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 3Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 4Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 5Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 6Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 7Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 8Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 9
(Date:12/26/2014)... England (PRWEB) December 26, 2014 The ... take place March 24-28, 2015 in Rome, Italy and ... line-up includes workshops on a wide variety ... as well as peak performance training in athletes. The ... around the world. , Biofeedback monitoring allows clients to ...
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on the ... for 2014. The awards program, created in 2000, is ... in the country. The program is a public/private partnership ... and Economic Development, the Pennsylvania State Council of the ... Business Journal. , Charlie Wilson, Vice President ...
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... December 25, 2014 Product liability lawsuits ... hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward ... an Order issued in the U.S. District Court, Northern ... convene an open conference on January 7, 2015, at ... Courthouse in West Palm Beach, Florida. The Conference is ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... help decrease the risk of breast cancer in postmenopausal women. ... ages 50 and 79 years old. The women were assessed ... on how many hours per week they exercised. The level ... 50 years was also considered. Researchers documented cases of breast ...
... group of cells, called satellite cells, that line the ... // their youthfulness. These cells rescue damaged muscles and ... new cells for future repairs. Previous studies have shown ... is activated by another protein called Delta. ,Researchers ...
... study reports the vessels in the eyes may be ... appears to narrow before blood // pressure exceeds normal ... to photograph the retinas of more than 3,500 people. ... Researchers also measured the blood pressure of the patients ...
... New research shows heart attacks without chest pain are more ... heart attack. Instead of chest pain //, some patients experience ... and vomiting. ,Researchers conducted a study to see how ... treated and how they recover. The study included information on ...
... new research chemotherapy after surgery may not be better ... cancer patients. // However, researchers say, the study looked ... new chemotherapy regimens may be better. ,In 1977, ... after surgery was initiated. More than 1,000 patients with ...
... Researchers have now found a way to genetically engineer the ... leaving healthy ones intact.// They did this by modifying one ... they had to boost the activity of another gene to ... Specialists say, “When the virus infects cells, it takes the ...
Cached Medicine News:
... the equivalent of 7.5 liters out of your ... need two machines for your high-flow patients! , ... Oxygen-Conserving Devices function like standard conservers, because they ... oxygen required to saturate a patient. However, ...
Proven and Efficient Stand-Alone Device. International Model. 50 psi....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
... ,Offers an average 5:1 increase in usage time ... of a standard cannula. , ,The combination ... ambulatory oxygen patients a superior alternative to liquid ... warranty. , ,NOTE: ...
Medicine Products: